The global market for Biosimilar Contract Manufacturing was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The increasing popularity of biosimilars in treating diseases, such as cancer, autoimmune diseases, blood disorders, and others, and the low cost of biosimilars as compared to biologics are some of the major factors driving the market.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Biosimilar Contract Manufacturing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biosimilar Contract Manufacturing.

The Biosimilar Contract Manufacturing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Biosimilar Contract Manufacturing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Biosimilar Contract Manufacturing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Biosimilar Contract Manufacturing Market Report

Report Metric	Details
Report Name	Biosimilar Contract Manufacturing Market
CAGR	5%
Segment by Type	Recombinant Non-glycosylated Proteins Recombinant Glycosylated Proteins
Segment by Application	Oncology Blood Disorders Growth Hormonal Deficiency Chronic & Autoimmune Disorders Rheumatoid Arthritis Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Boehringer Ingelheim Biopharmaceuticals GmbH, Lonza, Catalent, Inc., Biocon, IQVIA Inc., AGC Biologics, Samsung Biologics, WuXi Biologics, Element Materials Technology, Rentschler Biopharma SE, Avid Bioservices, Inc., Alcami Corporation, Inc., Fujifilm Kyowa Kirin Biologics Co., Ltd., Thermo Fisher Scientific Inc., Almac Group
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biosimilar Contract Manufacturing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Biosimilar Contract Manufacturing Market report?

Ans: The main players in the Biosimilar Contract Manufacturing Market are Boehringer Ingelheim Biopharmaceuticals GmbH, Lonza, Catalent, Inc., Biocon, IQVIA Inc., AGC Biologics, Samsung Biologics, WuXi Biologics, Element Materials Technology, Rentschler Biopharma SE, Avid Bioservices, Inc., Alcami Corporation, Inc., Fujifilm Kyowa Kirin Biologics Co., Ltd., Thermo Fisher Scientific Inc., Almac Group

What are the Application segmentation covered in the Biosimilar Contract Manufacturing Market report?

Ans: The Applications covered in the Biosimilar Contract Manufacturing Market report are Oncology, Blood Disorders, Growth Hormonal Deficiency, Chronic & Autoimmune Disorders, Rheumatoid Arthritis, Others

What are the Type segmentation covered in the Biosimilar Contract Manufacturing Market report?

Ans: The Types covered in the Biosimilar Contract Manufacturing Market report are Recombinant Non-glycosylated Proteins, Recombinant Glycosylated Proteins

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Biosimilar Contract Manufacturing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Recombinant Non-glycosylated Proteins

1.2.3 Recombinant Glycosylated Proteins

1.3 Market by Application

1.3.1 Global Biosimilar Contract Manufacturing Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Oncology

1.3.3 Blood Disorders

1.3.4 Growth Hormonal Deficiency

1.3.5 Chronic & Autoimmune Disorders

1.3.6 Rheumatoid Arthritis

1.3.7 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Biosimilar Contract Manufacturing Market Perspective (2020-2031)

2.2 Global Biosimilar Contract Manufacturing Growth Trends by Region

2.2.1 Global Biosimilar Contract Manufacturing Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Biosimilar Contract Manufacturing Historic Market Size by Region (2020-2025)

2.2.3 Biosimilar Contract Manufacturing Forecasted Market Size by Region (2026-2031)

2.3 Biosimilar Contract Manufacturing Market Dynamics

2.3.1 Biosimilar Contract Manufacturing Industry Trends

2.3.2 Biosimilar Contract Manufacturing Market Drivers

2.3.3 Biosimilar Contract Manufacturing Market Challenges

2.3.4 Biosimilar Contract Manufacturing Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Biosimilar Contract Manufacturing Players by Revenue

3.1.1 Global Top Biosimilar Contract Manufacturing Players by Revenue (2020-2025)

3.1.2 Global Biosimilar Contract Manufacturing Revenue Market Share by Players (2020-2025)

3.2 Global Biosimilar Contract Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Biosimilar Contract Manufacturing Revenue

3.4 Global Biosimilar Contract Manufacturing Market Concentration Ratio

3.4.1 Global Biosimilar Contract Manufacturing Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Biosimilar Contract Manufacturing Revenue in 2024

3.5 Global Key Players of Biosimilar Contract Manufacturing Head office and Area Served

3.6 Global Key Players of Biosimilar Contract Manufacturing, Product and Application

3.7 Global Key Players of Biosimilar Contract Manufacturing, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Biosimilar Contract Manufacturing Breakdown Data by Type

4.1 Global Biosimilar Contract Manufacturing Historic Market Size by Type (2020-2025)

4.2 Global Biosimilar Contract Manufacturing Forecasted Market Size by Type (2026-2031)

5 Biosimilar Contract Manufacturing Breakdown Data by Application

5.1 Global Biosimilar Contract Manufacturing Historic Market Size by Application (2020-2025)

5.2 Global Biosimilar Contract Manufacturing Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Biosimilar Contract Manufacturing Market Size (2020-2031)

6.2 North America Biosimilar Contract Manufacturing Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Biosimilar Contract Manufacturing Market Size by Country (2020-2025)

6.4 North America Biosimilar Contract Manufacturing Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Biosimilar Contract Manufacturing Market Size (2020-2031)

7.2 Europe Biosimilar Contract Manufacturing Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Biosimilar Contract Manufacturing Market Size by Country (2020-2025)

7.4 Europe Biosimilar Contract Manufacturing Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Biosimilar Contract Manufacturing Market Size (2020-2031)

8.2 Asia-Pacific Biosimilar Contract Manufacturing Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Biosimilar Contract Manufacturing Market Size by Region (2020-2025)

8.4 Asia-Pacific Biosimilar Contract Manufacturing Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Biosimilar Contract Manufacturing Market Size (2020-2031)

9.2 Latin America Biosimilar Contract Manufacturing Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Biosimilar Contract Manufacturing Market Size by Country (2020-2025)

9.4 Latin America Biosimilar Contract Manufacturing Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Biosimilar Contract Manufacturing Market Size (2020-2031)

10.2 Middle East & Africa Biosimilar Contract Manufacturing Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Biosimilar Contract Manufacturing Market Size by Country (2020-2025)

10.4 Middle East & Africa Biosimilar Contract Manufacturing Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Boehringer Ingelheim Biopharmaceuticals GmbH

11.1.1 Boehringer Ingelheim Biopharmaceuticals GmbH Company Details

11.1.2 Boehringer Ingelheim Biopharmaceuticals GmbH Business Overview

11.1.3 Boehringer Ingelheim Biopharmaceuticals GmbH Biosimilar Contract Manufacturing Introduction

11.1.4 Boehringer Ingelheim Biopharmaceuticals GmbH Revenue in Biosimilar Contract Manufacturing Business (2020-2025)

11.1.5 Boehringer Ingelheim Biopharmaceuticals GmbH Recent Development

11.2 Lonza

11.2.1 Lonza Company Details

11.2.2 Lonza Business Overview

11.2.3 Lonza Biosimilar Contract Manufacturing Introduction

11.2.4 Lonza Revenue in Biosimilar Contract Manufacturing Business (2020-2025)

11.2.5 Lonza Recent Development

11.3 Catalent, Inc.

11.3.1 Catalent, Inc. Company Details

11.3.2 Catalent, Inc. Business Overview

11.3.3 Catalent, Inc. Biosimilar Contract Manufacturing Introduction

11.3.4 Catalent, Inc. Revenue in Biosimilar Contract Manufacturing Business (2020-2025)

11.3.5 Catalent, Inc. Recent Development

11.4 Biocon

11.4.1 Biocon Company Details

11.4.2 Biocon Business Overview

11.4.3 Biocon Biosimilar Contract Manufacturing Introduction

11.4.4 Biocon Revenue in Biosimilar Contract Manufacturing Business (2020-2025)

11.4.5 Biocon Recent Development

11.5 IQVIA Inc.

11.5.1 IQVIA Inc. Company Details

11.5.2 IQVIA Inc. Business Overview

11.5.3 IQVIA Inc. Biosimilar Contract Manufacturing Introduction

11.5.4 IQVIA Inc. Revenue in Biosimilar Contract Manufacturing Business (2020-2025)

11.5.5 IQVIA Inc. Recent Development

11.6 AGC Biologics

11.6.1 AGC Biologics Company Details

11.6.2 AGC Biologics Business Overview

11.6.3 AGC Biologics Biosimilar Contract Manufacturing Introduction

11.6.4 AGC Biologics Revenue in Biosimilar Contract Manufacturing Business (2020-2025)

11.6.5 AGC Biologics Recent Development

11.7 Samsung Biologics

11.7.1 Samsung Biologics Company Details

11.7.2 Samsung Biologics Business Overview

11.7.3 Samsung Biologics Biosimilar Contract Manufacturing Introduction

11.7.4 Samsung Biologics Revenue in Biosimilar Contract Manufacturing Business (2020-2025)

11.7.5 Samsung Biologics Recent Development

11.8 WuXi Biologics

11.8.1 WuXi Biologics Company Details

11.8.2 WuXi Biologics Business Overview

11.8.3 WuXi Biologics Biosimilar Contract Manufacturing Introduction

11.8.4 WuXi Biologics Revenue in Biosimilar Contract Manufacturing Business (2020-2025)

11.8.5 WuXi Biologics Recent Development

11.9 Element Materials Technology

11.9.1 Element Materials Technology Company Details

11.9.2 Element Materials Technology Business Overview

11.9.3 Element Materials Technology Biosimilar Contract Manufacturing Introduction

11.9.4 Element Materials Technology Revenue in Biosimilar Contract Manufacturing Business (2020-2025)

11.9.5 Element Materials Technology Recent Development

11.10 Rentschler Biopharma SE

11.10.1 Rentschler Biopharma SE Company Details

11.10.2 Rentschler Biopharma SE Business Overview

11.10.3 Rentschler Biopharma SE Biosimilar Contract Manufacturing Introduction

11.10.4 Rentschler Biopharma SE Revenue in Biosimilar Contract Manufacturing Business (2020-2025)

11.10.5 Rentschler Biopharma SE Recent Development

11.11 Avid Bioservices, Inc.

11.11.1 Avid Bioservices, Inc. Company Details

11.11.2 Avid Bioservices, Inc. Business Overview

11.11.3 Avid Bioservices, Inc. Biosimilar Contract Manufacturing Introduction

11.11.4 Avid Bioservices, Inc. Revenue in Biosimilar Contract Manufacturing Business (2020-2025)

11.11.5 Avid Bioservices, Inc. Recent Development

11.12 Alcami Corporation, Inc.

11.12.1 Alcami Corporation, Inc. Company Details

11.12.2 Alcami Corporation, Inc. Business Overview

11.12.3 Alcami Corporation, Inc. Biosimilar Contract Manufacturing Introduction

11.12.4 Alcami Corporation, Inc. Revenue in Biosimilar Contract Manufacturing Business (2020-2025)

11.12.5 Alcami Corporation, Inc. Recent Development

11.13 Fujifilm Kyowa Kirin Biologics Co., Ltd.

11.13.1 Fujifilm Kyowa Kirin Biologics Co., Ltd. Company Details

11.13.2 Fujifilm Kyowa Kirin Biologics Co., Ltd. Business Overview

11.13.3 Fujifilm Kyowa Kirin Biologics Co., Ltd. Biosimilar Contract Manufacturing Introduction

11.13.4 Fujifilm Kyowa Kirin Biologics Co., Ltd. Revenue in Biosimilar Contract Manufacturing Business (2020-2025)

11.13.5 Fujifilm Kyowa Kirin Biologics Co., Ltd. Recent Development

11.14 Thermo Fisher Scientific Inc.

11.14.1 Thermo Fisher Scientific Inc. Company Details

11.14.2 Thermo Fisher Scientific Inc. Business Overview

11.14.3 Thermo Fisher Scientific Inc. Biosimilar Contract Manufacturing Introduction

11.14.4 Thermo Fisher Scientific Inc. Revenue in Biosimilar Contract Manufacturing Business (2020-2025)

11.14.5 Thermo Fisher Scientific Inc. Recent Development

11.15 Almac Group

11.15.1 Almac Group Company Details

11.15.2 Almac Group Business Overview

11.15.3 Almac Group Biosimilar Contract Manufacturing Introduction

11.15.4 Almac Group Revenue in Biosimilar Contract Manufacturing Business (2020-2025)

11.15.5 Almac Group Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Boehringer Ingelheim Biopharmaceuticals GmBh

Element Materials Technology

Rentschler Biopharma SE

Avid Bioservices Inc.

Alcami Corporation, Inc.

Thermo Fisher Scientific Inc

Almac Group

Fujifilm Kyowa Kirin Biologics Co., Ltd.

List of Tables

Table 1. Global Biosimilar Contract Manufacturing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Recombinant Non-glycosylated Proteins

Table 3. Key Players of Recombinant Glycosylated Proteins

Table 4. Global Biosimilar Contract Manufacturing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Biosimilar Contract Manufacturing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Biosimilar Contract Manufacturing Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Biosimilar Contract Manufacturing Market Share by Region (2020-2025)

Table 8. Global Biosimilar Contract Manufacturing Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Biosimilar Contract Manufacturing Market Share by Region (2026-2031)

Table 10. Biosimilar Contract Manufacturing Market Trends

Table 11. Biosimilar Contract Manufacturing Market Drivers

Table 12. Biosimilar Contract Manufacturing Market Challenges

Table 13. Biosimilar Contract Manufacturing Market Restraints

Table 14. Global Biosimilar Contract Manufacturing Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Biosimilar Contract Manufacturing Market Share by Players (2020-2025)

Table 16. Global Top Biosimilar Contract Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosimilar Contract Manufacturing as of 2024)

Table 17. Ranking of Global Top Biosimilar Contract Manufacturing Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Biosimilar Contract Manufacturing Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Biosimilar Contract Manufacturing, Headquarters and Area Served

Table 20. Global Key Players of Biosimilar Contract Manufacturing, Product and Application

Table 21. Global Key Players of Biosimilar Contract Manufacturing, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Biosimilar Contract Manufacturing Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Biosimilar Contract Manufacturing Revenue Market Share by Type (2020-2025)

Table 25. Global Biosimilar Contract Manufacturing Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Biosimilar Contract Manufacturing Revenue Market Share by Type (2026-2031)

Table 27. Global Biosimilar Contract Manufacturing Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Biosimilar Contract Manufacturing Revenue Market Share by Application (2020-2025)

Table 29. Global Biosimilar Contract Manufacturing Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Biosimilar Contract Manufacturing Revenue Market Share by Application (2026-2031)

Table 31. North America Biosimilar Contract Manufacturing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Biosimilar Contract Manufacturing Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Biosimilar Contract Manufacturing Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Biosimilar Contract Manufacturing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Biosimilar Contract Manufacturing Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Biosimilar Contract Manufacturing Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Biosimilar Contract Manufacturing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Biosimilar Contract Manufacturing Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Biosimilar Contract Manufacturing Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Biosimilar Contract Manufacturing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Biosimilar Contract Manufacturing Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Biosimilar Contract Manufacturing Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Biosimilar Contract Manufacturing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Biosimilar Contract Manufacturing Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Biosimilar Contract Manufacturing Market Size by Country (2026-2031) & (US$ Million)

Table 46. Boehringer Ingelheim Biopharmaceuticals GmbH Company Details

Table 47. Boehringer Ingelheim Biopharmaceuticals GmbH Business Overview

Table 48. Boehringer Ingelheim Biopharmaceuticals GmbH Biosimilar Contract Manufacturing Product

Table 49. Boehringer Ingelheim Biopharmaceuticals GmbH Revenue in Biosimilar Contract Manufacturing Business (2020-2025) & (US$ Million)

Table 50. Boehringer Ingelheim Biopharmaceuticals GmbH Recent Development

Table 51. Lonza Company Details

Table 52. Lonza Business Overview

Table 53. Lonza Biosimilar Contract Manufacturing Product

Table 54. Lonza Revenue in Biosimilar Contract Manufacturing Business (2020-2025) & (US$ Million)

Table 55. Lonza Recent Development

Table 56. Catalent, Inc. Company Details

Table 57. Catalent, Inc. Business Overview

Table 58. Catalent, Inc. Biosimilar Contract Manufacturing Product

Table 59. Catalent, Inc. Revenue in Biosimilar Contract Manufacturing Business (2020-2025) & (US$ Million)

Table 60. Catalent, Inc. Recent Development

Table 61. Biocon Company Details

Table 62. Biocon Business Overview

Table 63. Biocon Biosimilar Contract Manufacturing Product

Table 64. Biocon Revenue in Biosimilar Contract Manufacturing Business (2020-2025) & (US$ Million)

Table 65. Biocon Recent Development

Table 66. IQVIA Inc. Company Details

Table 67. IQVIA Inc. Business Overview

Table 68. IQVIA Inc. Biosimilar Contract Manufacturing Product

Table 69. IQVIA Inc. Revenue in Biosimilar Contract Manufacturing Business (2020-2025) & (US$ Million)

Table 70. IQVIA Inc. Recent Development

Table 71. AGC Biologics Company Details

Table 72. AGC Biologics Business Overview

Table 73. AGC Biologics Biosimilar Contract Manufacturing Product

Table 74. AGC Biologics Revenue in Biosimilar Contract Manufacturing Business (2020-2025) & (US$ Million)

Table 75. AGC Biologics Recent Development

Table 76. Samsung Biologics Company Details

Table 77. Samsung Biologics Business Overview

Table 78. Samsung Biologics Biosimilar Contract Manufacturing Product

Table 79. Samsung Biologics Revenue in Biosimilar Contract Manufacturing Business (2020-2025) & (US$ Million)

Table 80. Samsung Biologics Recent Development

Table 81. WuXi Biologics Company Details

Table 82. WuXi Biologics Business Overview

Table 83. WuXi Biologics Biosimilar Contract Manufacturing Product

Table 84. WuXi Biologics Revenue in Biosimilar Contract Manufacturing Business (2020-2025) & (US$ Million)

Table 85. WuXi Biologics Recent Development

Table 86. Element Materials Technology Company Details

Table 87. Element Materials Technology Business Overview

Table 88. Element Materials Technology Biosimilar Contract Manufacturing Product

Table 89. Element Materials Technology Revenue in Biosimilar Contract Manufacturing Business (2020-2025) & (US$ Million)

Table 90. Element Materials Technology Recent Development

Table 91. Rentschler Biopharma SE Company Details

Table 92. Rentschler Biopharma SE Business Overview

Table 93. Rentschler Biopharma SE Biosimilar Contract Manufacturing Product

Table 94. Rentschler Biopharma SE Revenue in Biosimilar Contract Manufacturing Business (2020-2025) & (US$ Million)

Table 95. Rentschler Biopharma SE Recent Development

Table 96. Avid Bioservices, Inc. Company Details

Table 97. Avid Bioservices, Inc. Business Overview

Table 98. Avid Bioservices, Inc. Biosimilar Contract Manufacturing Product

Table 99. Avid Bioservices, Inc. Revenue in Biosimilar Contract Manufacturing Business (2020-2025) & (US$ Million)

Table 100. Avid Bioservices, Inc. Recent Development

Table 101. Alcami Corporation, Inc. Company Details

Table 102. Alcami Corporation, Inc. Business Overview

Table 103. Alcami Corporation, Inc. Biosimilar Contract Manufacturing Product

Table 104. Alcami Corporation, Inc. Revenue in Biosimilar Contract Manufacturing Business (2020-2025) & (US$ Million)

Table 105. Alcami Corporation, Inc. Recent Development

Table 106. Fujifilm Kyowa Kirin Biologics Co., Ltd. Company Details

Table 107. Fujifilm Kyowa Kirin Biologics Co., Ltd. Business Overview

Table 108. Fujifilm Kyowa Kirin Biologics Co., Ltd. Biosimilar Contract Manufacturing Product

Table 109. Fujifilm Kyowa Kirin Biologics Co., Ltd. Revenue in Biosimilar Contract Manufacturing Business (2020-2025) & (US$ Million)

Table 110. Fujifilm Kyowa Kirin Biologics Co., Ltd. Recent Development

Table 111. Thermo Fisher Scientific Inc. Company Details

Table 112. Thermo Fisher Scientific Inc. Business Overview

Table 113. Thermo Fisher Scientific Inc. Biosimilar Contract Manufacturing Product

Table 114. Thermo Fisher Scientific Inc. Revenue in Biosimilar Contract Manufacturing Business (2020-2025) & (US$ Million)

Table 115. Thermo Fisher Scientific Inc. Recent Development

Table 116. Almac Group Company Details

Table 117. Almac Group Business Overview

Table 118. Almac Group Biosimilar Contract Manufacturing Product

Table 119. Almac Group Revenue in Biosimilar Contract Manufacturing Business (2020-2025) & (US$ Million)

Table 120. Almac Group Recent Development

Table 121. Research Programs/Design for This Report

Table 122. Key Data Information from Secondary Sources

Table 123. Key Data Information from Primary Sources

Table 124. Authors List of This Report

List of Figures

Figure 1. Biosimilar Contract Manufacturing Picture

Figure 2. Global Biosimilar Contract Manufacturing Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Biosimilar Contract Manufacturing Market Share by Type: 2024 VS 2031

Figure 4. Recombinant Non-glycosylated Proteins Features

Figure 5. Recombinant Glycosylated Proteins Features

Figure 6. Global Biosimilar Contract Manufacturing Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Biosimilar Contract Manufacturing Market Share by Application: 2024 VS 2031

Figure 8. Oncology Case Studies

Figure 9. Blood Disorders Case Studies

Figure 10. Growth Hormonal Deficiency Case Studies

Figure 11. Chronic & Autoimmune Disorders Case Studies

Figure 12. Rheumatoid Arthritis Case Studies

Figure 13. Others Case Studies

Figure 14. Biosimilar Contract Manufacturing Report Years Considered

Figure 15. Global Biosimilar Contract Manufacturing Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 16. Global Biosimilar Contract Manufacturing Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Biosimilar Contract Manufacturing Market Share by Region: 2024 VS 2031

Figure 18. Global Biosimilar Contract Manufacturing Market Share by Players in 2024

Figure 19. Global Top Biosimilar Contract Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosimilar Contract Manufacturing as of 2024)

Figure 20. The Top 10 and 5 Players Market Share by Biosimilar Contract Manufacturing Revenue in 2024

Figure 21. North America Biosimilar Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. North America Biosimilar Contract Manufacturing Market Share by Country (2020-2031)

Figure 23. United States Biosimilar Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Canada Biosimilar Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Biosimilar Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Biosimilar Contract Manufacturing Market Share by Country (2020-2031)

Figure 27. Germany Biosimilar Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. France Biosimilar Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. U.K. Biosimilar Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Italy Biosimilar Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Russia Biosimilar Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Nordic Countries Biosimilar Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Biosimilar Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Biosimilar Contract Manufacturing Market Share by Region (2020-2031)

Figure 35. China Biosimilar Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Japan Biosimilar Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. South Korea Biosimilar Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Southeast Asia Biosimilar Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. India Biosimilar Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Australia Biosimilar Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Biosimilar Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Biosimilar Contract Manufacturing Market Share by Country (2020-2031)

Figure 43. Mexico Biosimilar Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Brazil Biosimilar Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Biosimilar Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Biosimilar Contract Manufacturing Market Share by Country (2020-2031)

Figure 47. Turkey Biosimilar Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Saudi Arabia Biosimilar Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. UAE Biosimilar Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Boehringer Ingelheim Biopharmaceuticals GmbH Revenue Growth Rate in Biosimilar Contract Manufacturing Business (2020-2025)

Figure 51. Lonza Revenue Growth Rate in Biosimilar Contract Manufacturing Business (2020-2025)

Figure 52. Catalent, Inc. Revenue Growth Rate in Biosimilar Contract Manufacturing Business (2020-2025)

Figure 53. Biocon Revenue Growth Rate in Biosimilar Contract Manufacturing Business (2020-2025)

Figure 54. IQVIA Inc. Revenue Growth Rate in Biosimilar Contract Manufacturing Business (2020-2025)

Figure 55. AGC Biologics Revenue Growth Rate in Biosimilar Contract Manufacturing Business (2020-2025)

Figure 56. Samsung Biologics Revenue Growth Rate in Biosimilar Contract Manufacturing Business (2020-2025)

Figure 57. WuXi Biologics Revenue Growth Rate in Biosimilar Contract Manufacturing Business (2020-2025)

Figure 58. Element Materials Technology Revenue Growth Rate in Biosimilar Contract Manufacturing Business (2020-2025)

Figure 59. Rentschler Biopharma SE Revenue Growth Rate in Biosimilar Contract Manufacturing Business (2020-2025)

Figure 60. Avid Bioservices, Inc. Revenue Growth Rate in Biosimilar Contract Manufacturing Business (2020-2025)

Figure 61. Alcami Corporation, Inc. Revenue Growth Rate in Biosimilar Contract Manufacturing Business (2020-2025)

Figure 62. Fujifilm Kyowa Kirin Biologics Co., Ltd. Revenue Growth Rate in Biosimilar Contract Manufacturing Business (2020-2025)

Figure 63. Thermo Fisher Scientific Inc. Revenue Growth Rate in Biosimilar Contract Manufacturing Business (2020-2025)

Figure 64. Almac Group Revenue Growth Rate in Biosimilar Contract Manufacturing Business (2020-2025)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Pharmaceutical Labelling Machine Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-13D10320

Thu Feb 20 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Pharmaceutical Industry Thermal Transfer Overprinting (TTO) Equipment Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-27N15076

Thu Feb 20 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Pharmaceutical Strip Packaging Machines Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-36X10626

Thu Feb 20 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Triclopyr Acid Technical Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-37A19019

Thu Feb 20 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions